Asal Shirazi, Founder of ASA Foundation, shares insights into what drives inflammatory responses, including the role of ...

Human genetic variants associated with the development of systemic autoimmunity modulate B cell receptor (BCR) and co-receptor signalling, suggesting a role for dysregulated B cell signalling in ...

New research shows how a specially trained population of immune cells keeps the peace by preventing other immune cells from attacking their own. The study provides a better understanding of immune ...

Chimeric antigen receptor (CAR) T-cell therapy for blood cancers appeared less toxic, and patients' hospital stays were days shorter, when they also had autoimmune disease before starting the ...

Scientists have revealed a novel mechanism through which the immune system controls autoimmunity and cancer. In the special focus of the researchers were regulatory T cells -- a type of white blood ...

Immune dysregulation is often defined as an immune response that is directed against one of the body’s own tissues, cells or molecules (e.g. autoimmunity) or against an innocuous foreign molecule that ...

Alzheimer’s may be, at least in part, a disease of the immune system. Evidence supporting this comes from the study of genetics, infectious diseases, and the molecular machinations of the innate and ...

Artiva Biotherapeutics' CEO Fred Aslan, MD, discusses two ongoing trials for autoimmunity indications in the US and how AlloNK differs from traditional B-cell depletion strategies. In this ...

The Comprehensive Arthritis, Musculoskeletal, Bone, and Autoimmunity Center (CAMBAC) is hosting a one-day regional symposium titled Advances in Musculoskeletal Infection Research: From Bench to ...

Chimeric antigen receptor (CAR) T-cell therapy for certain cancers comes with important side effects such as cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome. Use ...